Cargando…

Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021

BACKGROUND: Limited data exist on risk factors for illicit stimulant use, including associations between prescription stimulant use/nonmedical use (NMU) and illicit stimulant use. METHODS: We used 2017–2021 data from adults assessed for substance use disorder (SUD) treatment using the National Addic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pickens, Cassandra M., Jones, Christopher M., Guy, Gery P., Dailey Govoni, Taryn, Green, Jody L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133667/
https://www.ncbi.nlm.nih.gov/pubmed/37123433
http://dx.doi.org/10.1016/j.dadr.2023.100153
_version_ 1785031605737226240
author Pickens, Cassandra M.
Jones, Christopher M.
Guy, Gery P.
Dailey Govoni, Taryn
Green, Jody L.
author_facet Pickens, Cassandra M.
Jones, Christopher M.
Guy, Gery P.
Dailey Govoni, Taryn
Green, Jody L.
author_sort Pickens, Cassandra M.
collection PubMed
description BACKGROUND: Limited data exist on risk factors for illicit stimulant use, including associations between prescription stimulant use/nonmedical use (NMU) and illicit stimulant use. METHODS: We used 2017–2021 data from adults assessed for substance use disorder (SUD) treatment using the National Addictions Vigilance Intervention and Prevention Program Addiction Severity Index-Multimedia Version® tool. Multivariable Poisson regression models analyzed associations between past 30-day prescription stimulant use as prescribed or NMU and past 30-day illicit stimulant use. Separate models examined past 30-day illicit stimulant, methamphetamine, and cocaine use. We explored problem severity across seven biopsychosocial domains (e.g., drug, psychiatric, family) by past 30-day prescription stimulant use/NMU and illicit stimulant use. RESULTS: Among 218,981 assessments, 1.8% reported prescription stimulant NMU; 1.6% reported use as prescribed. Past 30-day prescription stimulant NMU (vs. no use) was associated with past 30-day illicit stimulant use (adjusted prevalence ratio [aPR] [95% CI]: 2.67 [2.59, 2.75]), methamphetamine use (aPR: 2.81 [2.71, 2.92]), and cocaine use (aPR: 3.53 [3.33, 3.74]). Prescription stimulant use as prescribed (vs. no use) was associated with lower prevalence of past 30-day illicit stimulant use. Assessments reporting prescription stimulant NMU (vs. no use, or use as prescribed) appeared more likely to have moderate-to-extreme problem scores across biopsychosocial domains, indicating greater need for treatment or assistance. Assessments reporting prescription stimulant use as prescribed or NMU frequently reported opioids, alcohol, or other substances as their primary substance problem. CONCLUSIONS: Adults using illicit stimulants/nonmedically using prescription stimulants may benefit from care addressing polysubstance use, mental health, social, and recovery support services.
format Online
Article
Text
id pubmed-10133667
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101336672023-04-28 Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021 Pickens, Cassandra M. Jones, Christopher M. Guy, Gery P. Dailey Govoni, Taryn Green, Jody L. Drug Alcohol Depend Rep Full Length Report BACKGROUND: Limited data exist on risk factors for illicit stimulant use, including associations between prescription stimulant use/nonmedical use (NMU) and illicit stimulant use. METHODS: We used 2017–2021 data from adults assessed for substance use disorder (SUD) treatment using the National Addictions Vigilance Intervention and Prevention Program Addiction Severity Index-Multimedia Version® tool. Multivariable Poisson regression models analyzed associations between past 30-day prescription stimulant use as prescribed or NMU and past 30-day illicit stimulant use. Separate models examined past 30-day illicit stimulant, methamphetamine, and cocaine use. We explored problem severity across seven biopsychosocial domains (e.g., drug, psychiatric, family) by past 30-day prescription stimulant use/NMU and illicit stimulant use. RESULTS: Among 218,981 assessments, 1.8% reported prescription stimulant NMU; 1.6% reported use as prescribed. Past 30-day prescription stimulant NMU (vs. no use) was associated with past 30-day illicit stimulant use (adjusted prevalence ratio [aPR] [95% CI]: 2.67 [2.59, 2.75]), methamphetamine use (aPR: 2.81 [2.71, 2.92]), and cocaine use (aPR: 3.53 [3.33, 3.74]). Prescription stimulant use as prescribed (vs. no use) was associated with lower prevalence of past 30-day illicit stimulant use. Assessments reporting prescription stimulant NMU (vs. no use, or use as prescribed) appeared more likely to have moderate-to-extreme problem scores across biopsychosocial domains, indicating greater need for treatment or assistance. Assessments reporting prescription stimulant use as prescribed or NMU frequently reported opioids, alcohol, or other substances as their primary substance problem. CONCLUSIONS: Adults using illicit stimulants/nonmedically using prescription stimulants may benefit from care addressing polysubstance use, mental health, social, and recovery support services. Elsevier 2023-03-30 /pmc/articles/PMC10133667/ /pubmed/37123433 http://dx.doi.org/10.1016/j.dadr.2023.100153 Text en Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Report
Pickens, Cassandra M.
Jones, Christopher M.
Guy, Gery P.
Dailey Govoni, Taryn
Green, Jody L.
Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
title Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
title_full Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
title_fullStr Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
title_full_unstemmed Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
title_short Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
title_sort associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
topic Full Length Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133667/
https://www.ncbi.nlm.nih.gov/pubmed/37123433
http://dx.doi.org/10.1016/j.dadr.2023.100153
work_keys_str_mv AT pickenscassandram associationsbetweenprescriptionstimulantuseasprescribednonmedicaluseandillicitstimulantuseamongadultsevaluatedforsubstanceusetreatment20172021
AT joneschristopherm associationsbetweenprescriptionstimulantuseasprescribednonmedicaluseandillicitstimulantuseamongadultsevaluatedforsubstanceusetreatment20172021
AT guygeryp associationsbetweenprescriptionstimulantuseasprescribednonmedicaluseandillicitstimulantuseamongadultsevaluatedforsubstanceusetreatment20172021
AT daileygovonitaryn associationsbetweenprescriptionstimulantuseasprescribednonmedicaluseandillicitstimulantuseamongadultsevaluatedforsubstanceusetreatment20172021
AT greenjodyl associationsbetweenprescriptionstimulantuseasprescribednonmedicaluseandillicitstimulantuseamongadultsevaluatedforsubstanceusetreatment20172021